ProteoTech
Advancing Therapeutics and Diagnostics for Amyloid Diseases Since 1996
General Information
BounceWatch is an independent company data service, not affiliated with ProteoTech. To contact ProteoTech, visit proteotech.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does ProteoTech compare?
A PDF of ProteoTech and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting ProteoTech soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
From the desk
Is ProteoTech on your competitive set?
Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.
Book a 7-day ReadoutDiscover More
About ProteoTech
Business keywords: Pharmaceuticals, Therapeutics, Diagnostics, Amyloid Diseases, Alzheimer's Disease, Parkinson's Disease, Drug Development, Molecule Compound, Medical Research, Nasal Spray, Systemic Amyloidosis, Type 2 Diabetes, Proteins, Neurodegenerative Diseases
Funding Rounds & Investors (2)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Venture Round | $10.02M | - |
|
28 Jun 2011 |
| Debt Financing | $519.40K | - |
|
28 Apr 2009 |
ProteoTech Alternatives & Competitors
View All Alternatives
Restoring clarity in amyloid diseases
Developing a new approach to combating Alzheimer's disease and other neurodegenerative diseases.
Restoring Cellular Balance: Developing novel therapeutics for neurodegenerative disease
FAQ About ProteoTech
Source: BounceWatch company record for ProteoTech, https://bouncewatch.com/company/proteotech, updated 27 December 2024. When citing, please name BounceWatch and link this page.
